Streetbeat News

Analyst Ratings

BE

Jefferies analyst Lloyd Byrne has downgraded Bloom Energy from Buy to Hold and reduced the price target from $15 to $11.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2024 | 12:03 pm

GWRE

Oppenheimer analyst Ken Wong maintains an Outperform rating on Guidewire Software and raises the price target from $170 to $185.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2024 | 12:03 pm

LE

Lands' End (NASDAQ:LE) has been analyzed by 7 analysts, all of whom are bullish. The average 12-month price target is $18.71, up 2.3% from the previous target. Despite positive analyst sentiment, Lands' End faces financial challenges, including declining revenue and below-average profitability metrics.

Portfolio Pulse from Benzinga Insights

September 06, 2024 | 12:01 pm

BCYC

Bicycle Therapeutics (NASDAQ:BCYC) has received mixed analyst ratings over the past three months, with a current average price target of $40.8, down from $43.50. Analysts have varied opinions, with some maintaining 'Buy' or 'Outperform' ratings, while one analyst lowered their rating to 'Neutral'. The company faces challenges with a 17.86% revenue decline but maintains strong net margins and a low debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

September 06, 2024 | 12:01 pm

AFRM

Affirm Holdings (NASDAQ:AFRM) has received mixed analyst ratings over the past three months, with a recent average price target increase to $46.22. Analysts have raised their ratings and price targets, reflecting a positive outlook despite the company's financial challenges, such as low net margin and high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

September 06, 2024 | 12:00 pm

DTE

DTE Energy (NYSE:DTE) has been the subject of analysis by 9 financial analysts over the past three months, with opinions ranging from bullish to bearish. The average 12-month price target has increased to $128.33, with a high of $137.00 and a low of $111.00. Analysts have recently raised their ratings and price targets, indicating positive sentiment. DTE Energy has shown strong financial performance with a 7.12% revenue growth rate, a net margin of 11.2%, and a return on equity of 2.89%. However, its debt-to-equity ratio is higher than the industry average, indicating higher financial risk.

Portfolio Pulse from Benzinga Insights

September 06, 2024 | 12:00 pm

MGX

Analysts have mixed views on Metagenomi (NASDAQ:MGX), with recent ratings showing a shift towards bullish sentiment. The average 12-month price target has decreased by 12.37% to $11.83. Metagenomi's financials show strong revenue growth but below-average industry performance.

Portfolio Pulse from Benzinga Insights

September 06, 2024 | 12:00 pm

CNM

Analysts have recently adjusted their ratings and price targets for Core & Main (NYSE:CNM), reflecting a more cautious outlook. The average 12-month price target has decreased by 13.56% to $48.62. Despite positive financial metrics like revenue growth and strong profitability, analysts have lowered their expectations due to market conditions.

Portfolio Pulse from Benzinga Insights

September 06, 2024 | 12:00 pm

UNCY

Benchmark analyst Bruce Jackson has reiterated a Speculative Buy rating on Unicycive Therapeutics (NASDAQ:UNCY) and maintained a $3 price target.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2024 | 12:00 pm

IOT

BMO Capital analyst Daniel Jester maintains a Market Perform rating on Samsara (NYSE:IOT) and raises the price target from $40 to $44.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2024 | 11:58 am